GGrantIndex
Sort

8,912 grants matching sars cov 2

COPD(GENE): TASK B: "STEWARDSHIP OF BIOSPECIMEN AND DATA REPOSITORIES"

$922,055
Lee S Newman · National Jewish Health · N01 · FY2025 · HL

Biocontainment Research Support Service(s) Core

$921,558
Rachel M Olson · University Of Missouri-Columbia · UC7 · FY2024 · AI

Broadly neutralizing SARS-CoV-2 peptidic knobs

$921,025
Vaughn Vasil Smider · Applied Biomedical Science Institute · R01 · FY2024 · AI

Broadly neutralizing SARS-CoV-2 peptidic knobs

$921,025
Vaughn Vasil Smider · Applied Biomedical Science Institute · R01 · FY2025 · AI

Project 2

$919,757
Maria Virginia Pascual · St. Jude Children'S Research Hospital · U19 · FY2025 · AI

A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients

$917,957
Cedric Manlhiot · Johns Hopkins University · R61 · FY2021 · HD

India International Center for Excellence in Research

$917,866
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination

$916,382
John Ross Teijaro · Scripps Research Institute, The · R01 · FY2022 · AI

Structural and Functional Characterization of SARS-CoV-2 RNA Processing Factors

$916,339
Robin Stanley · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES

Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health Equity - (WHA REACH Equity Study)

$914,695
Joan Packenham · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

CardioPulmonary Vascular Biology COBRE

$913,498
Gaurav Choudhary · Ocean State Research Institute, Inc. · P30 · FY2023 · GM

Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD

$913,303
Adam Peter Spira · Johns Hopkins University · R01 · FY2023 · AG

Assessing the mechanisms underlying female sex-predominance in Long COVID

$913,012
Michael Joseph Peluso · University Of California, San Francisco · R01 · FY2025 · AI

Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases

$912,113
Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI

Human Energy and Body Weight Regulation Core

$912,097
Kong Chen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2022 · DK

The role of the microbiome in childhood disease

$912,046
Suchitra Hourigan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics

$908,934
Kenneth C Bagley · Orlance, Inc. · R44 · FY2020 · AI

Genetic Investigation of Covid 19 in Lung Disease

$908,674
Mark L Kahn · University Of Pennsylvania · R01 · FY2023 · HL

Transcriptional regulatory networks in living cells

$907,395
Richard A Young · Whitehead Institute For Biomedical Res · R01 · FY2019 · GM

Transcriptional regulatory networks in living cells

$907,395
Richard A Young · Whitehead Institute For Biomedical Res · R01 · FY2020 · GM

Discovering Affective Drug Combinations for Treating Covid-19

$906,886
Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

DISCOVAR:Disparities in Immune Response to SARS-CoV-2 in ARkansas

$906,648
Wendy N Nembhard · Univ Of Arkansas For Med Scis · U01 · FY2023 · CA

North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal

$906,511
Richard Douglas Moore · Johns Hopkins University · U01 · FY2020 · AI

Genetic Investigation of Covid 19 in Lung Disease

$904,852
Mark L Kahn · University Of Pennsylvania · R01 · FY2025 · HL

Lakota Center for Health Research

$904,086
Jeffrey A Henderson · Black Hills Ctr/American Indian Health · S06 · FY2025 · GM